Group 1 - Meikang Bio's subsidiary, Jiangxi Meikang Shengde Biotechnology Co., Ltd., has obtained the Medical Device Registration Certificate from the Jiangxi Provincial Drug Administration for products including the "Trace Element Testing Kit" [1] - For the fiscal year 2024, Meikang Bio's revenue composition will be 100% from medical devices [1] - As of the report date, Meikang Bio has a market capitalization of 4.1 billion yuan [1]